Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
TCD Pharma logo — company profile

TCD Pharma

Founded 2005 2 employees Series B Total: $10.44M Biotechnology

General Information

Company Name TCD Pharma
Founded Year 2005
Founders / Decision Makers
Team member
Employees 2
Industries Biotechnology
Funding Stage Series B
Social

Get notified when TCD Pharma moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About TCD Pharma

TCD Pharma is a prominent player in the biotechnology industry and has been identified as one of Spain’s top 5 biotech investment opportunities. Founded in 2005, the company is dedicated to pioneering the future of Oncology through the development of cutting-edge therapies that cater to unmet medical demands. TCD-717, the company's flagship product, is currently undergoing clinical trials, positioning TCD as the go-to partner in Spain for Oncology drug discovery and development. The company's strategic approach involves building its pipeline through in-licensing and partnerships, while also capitalizing on collaborations and outsourcing with leading Contract Research Organizations. This ensures that TCD remains at the forefront of Oncology drug development while effectively mitigating risks and lowering costs. TCD Pharma's recent €1.50M Series B investment on 10 January 2012 from CRB Inverbio underscores its growing potential and attractiveness to investors.

Taxonomy: biotech investment, oncology therapy, clinical trials, drug development, partnerships, contract research organizations

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series B •••••• 1 •••• •••• 10 Jan 2012
Series A •••••• 3
Investor Investor
•••• •••• 		17 Mar 2010

TCD Pharma Alternatives & Competitors

TCD Pharma vs
BioSeeker Group
BioSeeker Group Sweden

Award winning provider of the cancer drug intelligence solution 1stOncology

5 employees
Marketing
TCD Pharma vs
Nuformix Plc
Nuformix Plc United Kingdom

Unlocking Therapeutic Potential

5 employees
TCD Pharma vs
Elevation Oncology
Elevation Oncology United States

We are focused on discovering and developing selective cancer therapies to treat patients across a r...

Acquired
5 employees
Biopharma, Biotechnology

FAQ About TCD Pharma

Chosen as one of Spain’s top 5 biotech investment opportunities, TCD is focused on creating the future of Oncology by developing innovative therapies that address unmet medical needs. Established in 2005 and with one product, TCD-717, already in clinical trials the Company is positioning itself...
TCD Pharma was founded in 2005.
TCD Pharma operates in the following industries: Biotechnology.
TCD Pharma has approximately 2 employees.
TCD Pharma has completed 2 funding rounds, raising a total of $10.44M. The latest funding stage is Series B.
Top alternatives and competitors to TCD Pharma include BioSeeker Group, Nuformix Plc, Elevation Oncology, Astex Pharmaceuticals , DAVA Oncology. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
TCD Pharma and BioSeeker Group are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors TCD Pharma and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy